Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Efficacy and Safety of a Combination of Paracetamol, Chlorpheniramine Maleate and Phenylephrine in the Symptomatic Treatment of Common Cold : Phase IV Clinical Study


Affiliations
1 Medical Services, Centaur Pharmaceuticals Pvt. Ltd., India
2 Pharmacovigilance, Centaur Pharmaceuticals Pvt. Ltd., India
3 Dept of Pharmacology, Pad. Dr. D. Y. Patil Medical College, Navi Mumbai, India
     

   Subscribe/Renew Journal


Introduction and Background: Commoncold is one of the most frequently encountered disease in clinical practice. Though self-limiting, it accounts for major loss of work and school days so symptomatic therapy to treat the symptoms is often employed. A combination of Paracetamol, an antipyeretic/anti-inflammatory, Phenylephrine, a nasal decongestant and Chlorpheniramine maleate, an anti-histaminic is popular in the treatment of common cold. This Phase IV study evaluated the efficacy and safety of a combination of Paracetamol, Phenylephrine and Chlorpheniramine maleate in treatment of common cold. Methodology -Of 216 enrolled, 187 patients completed the study. Efficacy assessment was made by reduction in TSS and four point Likert-type scales. Safety assessment was made by analyzing the adverse events during trial. Results -Reductionin TSS from 6.58 (baseline) to 3.76 (day 3) and 1.78 (day 5). One point reduction in Likert-type symptom scale from Moderate to Mild took just 3 days. Nearly all the patients had >50% reduction in symptom score at all visit and majority of patients had complete relief from the symptom. 31 episodes of adverse events occurred and were of mild intensity. Conclusion - A combination of Paracetamol, Phenylephrine and Chlorpheniramine maleate is safe and effective in the treatment of common cold.

Keywords

Paracetamol, Phenylephrine, Chlorpheniramine Maleate, Common Cold, Total Symptom Score (TSS), Likert-Type Symptom Severity Scale.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Mossad SB, Treatment of the common cold, BMJ 1998, 317:33–36.
  • Ruth Martin Misener. Commentary on Review: a single dose of nasal decongestant reduces congestion in the short term in adults with the common cold; insufficient evidence exists on the effectiveness of repeated doses. Evidence-Based Nursing 2005; 8:12.
  • Madeline Simasek e al., Treatment of the Common Cold, American Family Physician, Volume 75, Number 4, February 15, 2007.
  • De Sutter et al., Antihistamines for the common cold, The Cochrane Library 2003, Issue 3.
  • Knollmann, Björn C., ed. Goodman & Gilman’s the pharmacological basis of therapeutics. Vol. 12. New York: McGraw-Hill Medical, 2011.
  • Mary Fran Peterlin et al. Nonprescription Chlorpheniramine Maleate and Submaximal Exercise Responses. Arch Phys Med Rehabil July 1998; 79: 827-831.
  • De Sutter et al., Oral antihistamine-decongestantanalgesic combinations forthe common cold (Review), The Cochrane Library 2012, Issue 2.
  • Picon et al., Symptomatic treatment of the common cold witha fixed-dose combination of paracetamol, chlorphenamine and phenylephrine: arandomized, placebo-controlled trial BMC Infectious Diseases 2013, 13:556.
  • Julia Fashner et al., Treatment of the Common Coldin Children and Adults American Family Physician, Volume 86, Number 2, July 2012.
  • Eccles, R., Fietze, I. and Rose, U.-B. (2014) Rationale for Treatment of Common Cold and Flu with Multi-Ingredient Combination Products for Multi-Symptom Relief in Adults. Open Journal of Respiratory Diseases, 4, 73-82.
  • DCGI Letter 4-012012-DC, CDSCO FDC Division dated 13-09-2013.

Abstract Views: 469

PDF Views: 0




  • Efficacy and Safety of a Combination of Paracetamol, Chlorpheniramine Maleate and Phenylephrine in the Symptomatic Treatment of Common Cold : Phase IV Clinical Study

Abstract Views: 469  |  PDF Views: 0

Authors

M. Kiran
Medical Services, Centaur Pharmaceuticals Pvt. Ltd., India
L. Pawaskar
Pharmacovigilance, Centaur Pharmaceuticals Pvt. Ltd., India
P. Yadav
Dept of Pharmacology, Pad. Dr. D. Y. Patil Medical College, Navi Mumbai, India

Abstract


Introduction and Background: Commoncold is one of the most frequently encountered disease in clinical practice. Though self-limiting, it accounts for major loss of work and school days so symptomatic therapy to treat the symptoms is often employed. A combination of Paracetamol, an antipyeretic/anti-inflammatory, Phenylephrine, a nasal decongestant and Chlorpheniramine maleate, an anti-histaminic is popular in the treatment of common cold. This Phase IV study evaluated the efficacy and safety of a combination of Paracetamol, Phenylephrine and Chlorpheniramine maleate in treatment of common cold. Methodology -Of 216 enrolled, 187 patients completed the study. Efficacy assessment was made by reduction in TSS and four point Likert-type scales. Safety assessment was made by analyzing the adverse events during trial. Results -Reductionin TSS from 6.58 (baseline) to 3.76 (day 3) and 1.78 (day 5). One point reduction in Likert-type symptom scale from Moderate to Mild took just 3 days. Nearly all the patients had >50% reduction in symptom score at all visit and majority of patients had complete relief from the symptom. 31 episodes of adverse events occurred and were of mild intensity. Conclusion - A combination of Paracetamol, Phenylephrine and Chlorpheniramine maleate is safe and effective in the treatment of common cold.

Keywords


Paracetamol, Phenylephrine, Chlorpheniramine Maleate, Common Cold, Total Symptom Score (TSS), Likert-Type Symptom Severity Scale.

References